{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:02:32Z","timestamp":1787162552347,"version":"build-2736575974"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Serotonin syndrome (SS) is a potentially life-threatening adverse drug reaction resulting from excessive serotonergic activity in the central and peripheral nervous systems. Tramadol produces analgesia through \u03bc-opioid receptor agonism while also inhibiting the reuptake of serotonin and norepinephrine. Linezolid an oxazolidinone antibacterial agent, possesses reversible, non-selective monoamine oxidase inhibitory activity. Through distinct pharmacological mechanisms, both agents enhance serotonergic neurotransmission and may theoretically increase the risk of SS when used concomitantly. We report the case of an elderly woman who developed serotonin syndrome shortly after receiving tramadol and linezolid for ischemic lower-limb pain complicated by severe infection. The patient fulfilled the Hunter diagnostic criteria, presenting with hyperthermia, tremor, myoclonus, hyperreflexia, muscle rigidity, diaphoresis, and flushing. The symptoms resolved rapidly after discontinuation of the suspected medications and initiation of supportive treatment. Although several real-world studies have suggested that the overall incidence of SS associated with concomitant linezolid and serotonergic agents is relatively low, this report highlights that individualized risk assessment remains essential in elderly patients with multiple comorbidities and polypharmacy. Careful evaluation of potential drug interactions and close clinical monitoring are therefore warranted when anti-infective and analgesic therapies with serotonergic properties are administered concurrently.<\/jats:p>","DOI":"10.3389\/fphar.2026.1825964","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:02:01Z","timestamp":1780034521000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Serotonin syndrome associated with concomitant tramadol and linezolid therapy: a case report and literature review"],"prefix":"10.3389","volume":"17","author":[{"given":"Huixin","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Pharmacy, North China University of Science and Technology Afffliated Hospital","place":["Tangshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, North China University of Science and Technology Afffliated Hospital","place":["Tangshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leng","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s40261-023-01326-y","article-title":"Clinical and laboratory factors related to seizure and serotonin toxicity in tramadol intoxication: an Egyptian study","volume":"43","author":"Ali","year":"2023","journal-title":"Clin. Drug Investig."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/biomedicines13071690","article-title":"Investigation into the effects of tramadol, citalopram, tianeptine, and their combinations on rat brain tissue","volume":"13","author":"Ates","year":"2025","journal-title":"Biomedicines"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jfcm.jfcm_236_23","article-title":"Serotonin syndrome: an often-neglected medical emergency","volume":"31","author":"Badar","year":"2024","journal-title":"J. Fam. Community Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2247426","DOI":"10.1001\/jamanetworkopen.2022.47426","article-title":"Association of linezolid with risk of serotonin syndrome in patients receiving antidepressants","volume":"5","author":"Bai","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.16br01966","article-title":"Serotonin syndrome: prophylactic treatment with cyproheptadine","volume":"18","author":"Deardorff","year":"2016","journal-title":"Prim. Care Companion CNS Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/jcp.0000000000001798","article-title":"Prevalence and correlates of serotonin syndrome in real-world inpatients","volume":"44","author":"Di Salvo","year":"2024","journal-title":"J. Clin. Psychopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00228-023-03596-z","article-title":"Serotonin syndrome: a pharmacovigilance comparative study of drugs affecting serotonin levels","volume":"80","author":"Elli","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00228-020-02990-1","article-title":"Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic\/pharmacodynamic analysis","volume":"77","author":"Gatti","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/026988119901300111","article-title":"The serotonin syndrome and its treatment","volume":"13","author":"Gillman","year":"1999","journal-title":"J. Psychopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4103\/aer.AER_173_18","article-title":"Serotonin syndrome induced by combined use of sertraline and linezolid","volume":"13","author":"Hasani","year":"2019","journal-title":"Anesth. Essays Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s00740-023-00492-1","article-title":"Central anticholinergic, neuroleptic malignant and serotonin syndromes","volume":"26","author":"H\u00f6lle","year":"2023","journal-title":"Wien Klin. Mag."},{"key":"B12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.wnf.0000177642.89888.85","article-title":"The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment","volume":"28","author":"Isbister","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.5694\/j.1326-5377.2007.tb01282.x","article-title":"Serotonin toxicity: a practical approach to diagnosis and treatment","volume":"187","author":"Isbister","year":"2007","journal-title":"Med. J. Aust."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4837","DOI":"10.3390\/ijms22094837","article-title":"Serotonin-its synthesis and roles in the healthy and the critically ill","volume":"22","author":"Kanova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/JCP.0000000000000751","article-title":"Incidence of serotonin syndrome with combined use of linezolid and serotonin reuptake inhibitors compared with linezolid monotherapy","volume":"37","author":"Karkow","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"106843","DOI":"10.1016\/j.ijantimicag.2023.106843","article-title":"Real-world evaluation of linezolid-associated serotonin toxicity with and without concurrent serotonergic agents","volume":"62","author":"Kufel","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/dtb.2021.000032","article-title":"Serotonin syndrome","volume":"60","author":"Maitland","year":"2022","journal-title":"Drug Ther. Bull."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e59975","DOI":"10.7759\/cureus.59975","article-title":"Causality, severity, preventability and predictability assessments scales for adverse drug reactions: a review","volume":"16","author":"Manjhi","year":"2024","journal-title":"Cureus"},{"key":"B19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/bcpt.13912","article-title":"Serotonin syndrome-A focused review","volume":"133","author":"Mikkelsen","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1001\/jamapsychiatry.2020.3643","article-title":"Association of CYP2C19 and CYP2D6 poor and intermediate metabolizer status with antidepressant and antipsychotic exposure: a systematic review and meta-analysis","volume":"78","author":"Milosavljevic","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijregi.2022.09.008","article-title":"Risk of serotonin syndrome in acutely ill patients receiving linezolid and opioids concomitantly: a retrospective cohort study","volume":"5","author":"Mitwally","year":"2022","journal-title":"IJID Reg."},{"key":"B22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/s0006-8993(00)03020-1","article-title":"Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome","volume":"890","author":"Nisijima","year":"2001","journal-title":"Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.3390\/ijms23063365","article-title":"Hyperthermia and serotonin: the quest for a better cyproheptadine","volume":"23","author":"Petroianu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e38897","DOI":"10.7759\/cureus.38897","article-title":"Serotonin syndrome: the role of pharmacology in understanding its occurrence","volume":"15","author":"Poian","year":"2023","journal-title":"Cureus"},{"key":"B25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/pharmacy11060182","article-title":"The association of serotonin toxicity with combination linezolid-serotonergic agent therapy: a systematic review and meta-analysis","volume":"11","author":"SanFilippo","year":"2023","journal-title":"Pharm. (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13023-024-03227-5","article-title":"Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis","volume":"19","author":"Sweileh","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"ofac331","DOI":"10.1093\/ofid\/ofac331","article-title":"A cross-sectional analysis of linezolid in combination with methadone or buprenorphine as a cause of serotonin toxicity","volume":"9","author":"Traver","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3000605251315355","DOI":"10.1177\/03000605251315355","article-title":"Linezolid and serotonin syndrome","volume":"53","author":"Wali","year":"2025","journal-title":"J. Int. Med. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.12173\/j.issn.1005-0698.202503005","article-title":"Analysis of a case of 5-hydroxytryptamine syndrome caused by oxycodone hydrochloride sustained-release tablets","volume":"34","author":"Zhang","year":"2025","journal-title":"Chin. J. Pharmacoepidemiol"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1825964\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:02:02Z","timestamp":1780034522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1825964\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":29,"alternative-id":["10.3389\/fphar.2026.1825964"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1825964","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1825964"}}